Search results for "cancer diagnosis"

KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy

DCN Dx specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research.

The technology helping to save young lives by enabling quick testing of patient samples

Dr. Luca Quagliata explains how molecular profiling could transform the way we treat cancer, and how his work is enabling the global adoption of this technology – in the face of clinical challenges and diversity

Electrochemical Probe Scanner  

The new genetic analyzer supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing

Researchers at MedAustron Ion Therapy Center and Karl Landsteiner University of Health Sciences improve methods for energy deposition into tumour tissue

First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy

Cielo Dx qPCR systems for in vitro diagnostic (IVD) use brings the accuracy and sensitivity that clinical laboratories demand.

Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers